中国介入心脏病学杂志
中國介入心髒病學雜誌
중국개입심장병학잡지
CHINESE JOURNAL OF INTERVENTIONAL CARDIOLOGY
2014年
9期
574-577
,共4页
王立新%王建斌%杨丽%李富军%赵宇%何晓雷%颜翠萍
王立新%王建斌%楊麗%李富軍%趙宇%何曉雷%顏翠萍
왕립신%왕건빈%양려%리부군%조우%하효뢰%안취평
急性心肌梗死%血管成形术%经皮冠状动脉介入治疗%血栓抽吸
急性心肌梗死%血管成形術%經皮冠狀動脈介入治療%血栓抽吸
급성심기경사%혈관성형술%경피관상동맥개입치료%혈전추흡
Acute myocardial infarction%Angioplasty%Percutaneous coronary intervention%Thrombus aspiration
目的:探讨血栓抽吸联合替罗非班对急性心肌梗死血栓病变患者心功能及预后的影响。方法选取北京市延庆县医院收治的372例急性ST段抬高心肌梗死(STEMI)患者为观察对象,随机分为观察组(183例)和对照组(189例),观察组患者在常规经皮冠状动脉介入治疗(PCI)基础上采用血栓抽吸联合替罗非班治疗,对照组进行常规PCI,比较两组患者治疗效果、术后并发症以及不良反应等。结果观察组中术后TIMI血流分级Ⅲ级患者152例(83.1%),高于对照组的140例(74.1%),观察组血流改善情况与对照组比较,差异有统计学意义(P<0.05);观察组患者术后7、30 d时左心室射血分数(LVEF)分别为(60.4±6.1)%、(64.3±5.6)%,高于对照组的(52.4±5.9)%、(55.4±5.7)%,差异有统计学意义(P<0.05);观察组患者中出血36例(19.7%),对照组患者中出血26例(13.8%),两组患者出血发生率比较,差异无统计学意义(P>0.05);观察组患者中30 d内主要不良心脏事件(MACE)10例(5.5%),对照组30 d内MACE 22例(11.6%),两组患者比较,差异有统计学意义(P<0.05);两组患者均未发生血小板减少症。结论血栓抽吸联合替罗非班应用于急性心肌梗死血栓病变PCI中,可显著改善术后冠状动脉的血流灌注,提高近期左心室射血功能,降低30 d内MACE发生率。
目的:探討血栓抽吸聯閤替囉非班對急性心肌梗死血栓病變患者心功能及預後的影響。方法選取北京市延慶縣醫院收治的372例急性ST段抬高心肌梗死(STEMI)患者為觀察對象,隨機分為觀察組(183例)和對照組(189例),觀察組患者在常規經皮冠狀動脈介入治療(PCI)基礎上採用血栓抽吸聯閤替囉非班治療,對照組進行常規PCI,比較兩組患者治療效果、術後併髮癥以及不良反應等。結果觀察組中術後TIMI血流分級Ⅲ級患者152例(83.1%),高于對照組的140例(74.1%),觀察組血流改善情況與對照組比較,差異有統計學意義(P<0.05);觀察組患者術後7、30 d時左心室射血分數(LVEF)分彆為(60.4±6.1)%、(64.3±5.6)%,高于對照組的(52.4±5.9)%、(55.4±5.7)%,差異有統計學意義(P<0.05);觀察組患者中齣血36例(19.7%),對照組患者中齣血26例(13.8%),兩組患者齣血髮生率比較,差異無統計學意義(P>0.05);觀察組患者中30 d內主要不良心髒事件(MACE)10例(5.5%),對照組30 d內MACE 22例(11.6%),兩組患者比較,差異有統計學意義(P<0.05);兩組患者均未髮生血小闆減少癥。結論血栓抽吸聯閤替囉非班應用于急性心肌梗死血栓病變PCI中,可顯著改善術後冠狀動脈的血流灌註,提高近期左心室射血功能,降低30 d內MACE髮生率。
목적:탐토혈전추흡연합체라비반대급성심기경사혈전병변환자심공능급예후적영향。방법선취북경시연경현의원수치적372례급성ST단태고심기경사(STEMI)환자위관찰대상,수궤분위관찰조(183례)화대조조(189례),관찰조환자재상규경피관상동맥개입치료(PCI)기출상채용혈전추흡연합체라비반치료,대조조진행상규PCI,비교량조환자치료효과、술후병발증이급불량반응등。결과관찰조중술후TIMI혈류분급Ⅲ급환자152례(83.1%),고우대조조적140례(74.1%),관찰조혈류개선정황여대조조비교,차이유통계학의의(P<0.05);관찰조환자술후7、30 d시좌심실사혈분수(LVEF)분별위(60.4±6.1)%、(64.3±5.6)%,고우대조조적(52.4±5.9)%、(55.4±5.7)%,차이유통계학의의(P<0.05);관찰조환자중출혈36례(19.7%),대조조환자중출혈26례(13.8%),량조환자출혈발생솔비교,차이무통계학의의(P>0.05);관찰조환자중30 d내주요불양심장사건(MACE)10례(5.5%),대조조30 d내MACE 22례(11.6%),량조환자비교,차이유통계학의의(P<0.05);량조환자균미발생혈소판감소증。결론혈전추흡연합체라비반응용우급성심기경사혈전병변PCI중,가현저개선술후관상동맥적혈류관주,제고근기좌심실사혈공능,강저30 d내MACE발생솔。
Objective To evaluate the prognestic effect of thrombus aspiration combined tirofiban in patients of acute myocardial infarction. Methods 372 patients with acute ST segment elevation myocardial infarction were randomly divided into the observation group (n=183) and the control group (n=189). Patients in the observation group received thrombus aspiration combined tirofiban additional to conventional treatment, and cases in the control group received routine treatment. The curative effect, postoperative complications and adverse reactions were compared between the 2 groups. Results The postoperative TIMI classⅢperfusion was achieved in 152 cases (83.1%) in the observation group and 140 cases (74.1%) in the control group (P < 0.05). The left heart ejection fraction of the observation group on 7 and 30 days after surgery was (60.4±6.1)%and (64.3±5.6)%respectively which was higher than the control group with (52.4±5.9)% and (55.4±5.7)% on 7 and 30 days respectively (P < 0.05). Bleeding events were recorded in 36 cases(19.7%) in the observation group rensus 26 versus (13.8%) in the control group (P>0.05). MACE reorded within 30 d post operation was 10 cases(5.5%) in the observation group and 22 cases (11.6%) in the control group (P < 0.05). No thrombocytopenia recorded in both groups. Conclusions Thrombus aspiration combined tirofiban for patients with acute myocardial infarction during PCI can improve the postoperative coronary artery perfusion, left ventricular ejection function and reduce the incidence of MACE within 30 days.